Past event

This event has already taken place

Want to be part of a future PharmaBrands event? Get in touch and we’ll help you find the right one.

Dr. Bobby Yanagawa

Program Director and Associate Professor · Division of Cardiac Surgery at the University of Toronto

Become a speaker
Division of Cardiac Surgery at the University of Toronto

Dr. Bobby Yanagawa

Program Director and Associate Professor

Division of Cardiac Surgery at the University of Toronto

Dr. Bobby Yanagawa is the Division Head, Division of Cardiac Surgery, St. Michael's Hospital and Program Director, Division of Cardiac Surgery, University of Toronto. He holds the SURE General Contractors Inc. Professorship in Infective Endocarditis. Dr. Yanagawa completed residency training at the University of Toronto and INOVA Fairfax Hospital (Fairfax, VA) and an advanced valvular fellowship at Mount Sinai Hospital (New York, NY). His research training includes a PhD at the University of British Columbia and post-doctoral fellowships at the University of Wales College of Medicine (Cardiff, UK) and National Cardiovascular Center (Osaka, Japan). His clinical and academic focus is surgical revascularization and surgery for infective endocarditis. He is the Director of the Canadian Society of Cardiac Surgeons Equity, Diversity and Inclusion Taskforce. His research interests include clinical outcome studies of ischemic and valvular heart disease. He has published over 100 peer-reviewed articles, 40 reviews and 15 book chapters. He is on the editorial board of the Journal of Thoracic and Cardiovascular Surgery, Canadian Journal of Cardiology, Guest Editor - Current Opinions of Cardiology and Feature Editor, Annals of Thoracic Surgery.

Dr. Bobby Yanagawa

Sessions

  1. Dr. Bobby Yanagawa

    Dr. Bobby Yanagawa

    12:00 PM – 12:25 PM

    Follow-on Case Study: Democratizing Healthcare with Agentic AI - The Results!

    • Follow-up case study on the real-world deployment of an agentic AI clinical advisor across CABG patients pre- and post-surgery: what worked, what surprised us, and where challenges remain.
    • Insights from over 50 patient experiences, including early findings from post-pilot surveys and anonymized excerpts from patient–AI interactions
    • What these findings mean for the future of patient support and life sciences engagement.

    • Dr. Bobby Yanagawa, Program Director and Associate Professor, Division of Cardiac Surgery at the University of Toronto

    • Murray Forrestall, Partner , RXCHAINGE AI